Related Experiment Videos

Erythrophagocytosis in vivo in sickle cell anemia

Insights

Sickle red blood cells (RBCs) in patients with sickle cell anemia (SS) show increased in vivo erythrophagocytosis (Ep). This indicates significant membrane injury, validating in vitro findings and suggesting a role for cell senescence.

Area of Science:

  • Hematology
  • Cell Biology
  • Pathophysiology

Background:

  • Sickle red blood cells (RBCs) exhibit increased susceptibility to phagocytosis by macrophages in vitro.
  • Erythrophagocytosis (Ep), the engulfment of RBCs by macrophages, is a key process in RBC clearance.

Purpose of the Study:

  • To investigate the occurrence of in vivo erythrophagocytosis (Ep) in patients with sickle cell anemia (SS).
  • To correlate Ep findings with clinical parameters and validate in vitro observations.

Main Methods:

  • Examination of blood smears from 27 steady-state SS patients and controls.
  • Differential white blood cell (WBC) counts to detect Ep.
  • Comparison of hematocrit values between Ep-positive and Ep-negative SS patients.

Main Results:

  • Ep was detected in 37% of SS patients (1-6/1,000 WBC or 1-10/100 monocytes).
  • No Ep was observed in normal controls or splenectomized subjects.
  • SS patients with Ep had significantly lower mean hematocrit values.

Conclusions:

  • In vivo Ep occurs in a significant proportion of SS patients, indicating membrane injury of sickle RBCs.
  • These findings support in vitro observations regarding sickle RBC phagocytosis.
  • The mechanism of RBC senescence may contribute to the induction of Ep in sickle cell anemia.

Related Concept Videos